June, 27 2026 Saturday 13:54 Hrs
Last update 11-9-2025
  • SENSEX :   77,100.47

  • Commodity broking firm in India109.25( 0.14%) 25-Jun-2026
Positive
Sensex 77100.47 109.25  (0.14) 25-Jun-2026
Previous Day Close 76991.22
Today's High/Low
High Low
  •  
  •  
77803.18 76993.16

Company News Details

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
148.85
446792.16
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.86
 

Sun Pharmaceutical Industries Ltd
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271 crore
Jun 22,2026

Innovcare Lifesciences is engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products. The revenue from operations for FY 2025-26 was Rs 94.06 crore.

Sun Pharma stated that this acquisition is being done to strengthen product portfolio of the company.

The company expects to complete this transaction before 31 July 2026.

Sun Pharmaceutical Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and active pharmaceutical ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world, with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.

The company had reported 26.24% rise in consolidated net profit to Rs 2,714.03 crore in Q4 FY26 as against Rs 2,149.88 crore posted in the same period year ago. Total revenue from operations increased 12.75% YoY to Rs 14,611.79 crore in the quarter ended 31 March 2026.

The scrip advanced 0.85% to currently trade at Rs 1852.70 on the BSE.

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.